Medigus Ltd. announced that the China Food and Drug Administration, or CFDA, has approved the commencement of the first multi-center MUSE™ Clinical Study in China.
First purchase order (PO) for the MUSE™ system in Italy from INNOVAMEDICA S.p.A.
No immediate effect on the listing or trading of Medigus' American depositary shares on the NASDAQ Stock Market.
Vice President of Sales and Marketing, Yaron Silberman, to Present at the Inventors Corner Session on January 4, 2017 at 5:50pm IST
Medigus today announced the completion of a live transoral fundoplication (TF) procedure using the Medigus Ultrasonic Surgical Endostapler (MUSE™) system.
Medigus Ltd. today announced that it has entered into a definitive agreement with institutional investors providing for the issuance of 1,139,170 American depositary shares (ADS) at a purchase price per ADS of $0.67 in a registered direct offering.
Medigus Ltd. announced today that it has received a Notice of Intention to Grant a Patent from the European Patent Office (EPO) for its micro ScoutCam™ miniature camera technology.
Medigus Ltd. today announced financial results for the third quarter ended September 30, 2016.
Medigus entered into definitive securities purchase agreements with two institutional investors.